eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2023
vol. 9
 
Share:
Share:
abstract:
Review paper

The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes

Nasim Rahimi Farsi
1, 2
,
Bahman Naghipour
3
,
Parviz Shahabi
4
,
Reza Safaralizadeh
5
,
Khalil Hajiasgharzadeh
1
,
Narges Dastmalchi
2
,
Mohammad Reza Alipour
1, 4

  1. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. Department of Biology, University College of Nabi Akram, Tabriz, Iran
  3. Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  4. Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  5. Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
Clin Exp HEPATOL 2023; 9, 4: 307-319
Online publish date: 2023/09/28
View full text Get citation
 
PlumX metrics:
Hepatocellular carcinoma (HCC) is a severe malignant liver cancer with a poor prognosis and a high mortality rate. This carcinoma is a multistage process that begins with chronic hepatitis and progresses to cirrhosis, dysplastic nodules, and eventually HCC. However, the exact molecular etiology remains unclear. MicroRNAs (miRs) are small non-coding RNAs that modulate the expression of numerous genes. These molecules have become significant participants in several functions, including cell proliferation, differentiation, development, and tumorrelated properties. They have a pivotal role in carcinogenesis as oncogenes or tumor suppressor genes. Furthermore, some investigations have shown that particular miRs might be used as predictive or diagnostic markers and therapeutic targets in HCC therapy. This review study summarizes the current level of knowledge on the role of miRs in the initiation and progression of HCC.
keywords:

hepatocellular carcinoma (HCC), microRNA, therapeutic target, oncogene, tumor suppressor

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.